Trial initiated at Fudan University Shanghai Cancer Center (FUSCC) under the leadership of Leading Principal Investigator ...

The call is that falling long rates are repricing everything outside tech right now rather than earnings, and Cramer says growth stocks away from semis are the clean way to play it. He is warning ...

Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid) has been granted an accelerated approval by the FDA as a ...

Discover how MahaVastu's Industrial Vastu protocol revolutionizes factory productivity. This spatial management framework ...

At least 1,000 women with uterine fibroids and adenomyosis have undergone non-surgical treatment at the Fibroid Care Centre, Nordica, in a major milestone for advanced gynaecological care in Nigeria.

Market is driven by food quality monitoring, environmental sensing, and growing demand for rapid odor detection.

UroGen Pharma stock falls 2.2% to $32.72 today. The first patient begins treatment in a Phase 1 study of UGN-501.

WT outcomes have improved substantially through progress in molecular diagnosis, chemotherapy, radiotherapy, and surgery. Yet ...

U.S. stocks rally widens as falling oil prices and lower Treasury yields boost sectors beyond technology, lifting healthcare ...

First plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone.

Meet the founder who has launched her “dream” business at the former Workbridge site, and she hopes the destination will be ...